SHRUNKEN PORE SYNDROME: AN OVERLOOKED ENTITY WITH MAJOR CLINICAL CONSEQUENCES

Shrunken Pore Syndrome (SPS) represents an underappreciated form of kidney filtration disorder that is characterized by inadequate filtration of medium-sized molecules in the presence of a relatively preserved glomerular filtration rate (GFR). SPS is usually detected when the GFR measured based on cystatin C levels is significantly below the GFR obtained based on creatinine. SPS has received considerable attention recently due to its association with unfavorable clinical outcomes such as cardiovascular disease, progression of chronic kidney disease, frailty, hospitalization, and death. SPS occurs as a consequence of structural changes in the glomerular filtration barrier that impair the filtration of larger molecules. SPS may be observed in diabetic, hypertensive, inflammatory, or age-related conditions; however, it often goes undetected due to normal results of kidney evaluation based on creatinine. Therefore, early detection of SPS is crucial since it provides a possibility of predicting an unfavorable outcome and identifying patients at risk. The current literature highlights the importance of measuring cystatin C in evaluating kidney function.

• Bolton, G. R., Deen, W. M., & Daniels, B. S. (1998b). Assessment of the charge selectivity of glomerular basement membrane using Ficoll sulfate. American Journal of Physiology-Renal Physiology, 274(5): F889–F896. https://doi.org/10.1152/ajprenal.1998.274.5.f889
• Vollenbröker, B., George, B., Wolfgart, M., Saleem, M. A., Pavenstädt, H., & Weide, T. (2008). mTOR regulates expression of slit diaphragm proteins and cytoskeleton structure in podocytes. American Journal of Physiology-Renal Physiology, 296(2): F418–F426. https://doi.org/10.1152/ajprenal.90319.2008
• Wilkie, M. (2015). Introduction to Point-counterpoint: Mechanisms of Glomerular Filtration: Pores versus an Electrical Field. Peritoneal Dialysis International, 35(1): 4. https://doi.org/10.3747/pdi.2014.00325
• Öberg, C. M., & Rippe, B. (2013). Quantification of the electrostatic properties of the glomerular filtration barrier modeled as a charged fiber matrix separating anionic from neutral Ficoll. American Journal of Physiology-Renal Physiology, 304(6): F781–F787. https://doi.org/10.1152/ajprenal.00621.2012
• Smith, A. C., Toto, R., & Bakris, G. L. (1998). Differential effects of calcium channel blockers on size selectivity of proteinuria in diabetic glomerulopathy. Kidney International, 54(3):      889–896. https://doi.org/10.1046/j.1523-1755.1998.00055.x
• Chelazzi, C., Villa, G., Mancinelli, P., De Gaudio, A. R., & Adembri, C. (2015). Glycocalyx and sepsis-induced alterations in vascular permeability. Critical Care, 19(1): 26. https://doi.org/10.1186/s13054-015-0741-z
• Knabb, M. T., Pérez‐Aguilar, S., Torres‐Tirado, D., Ramiro‐Díaz, J., & Rubio, R. (2010). Biochemical alterations in coronary endothelial luminal membranes during ischemia and reperfusion in isolated perfused guinea pig hearts. The FASEB Journal, 24(S1). https://doi.org/10.1096/fasebj.24.1_supplement.598.4
• Leion, F., Hegbrant, J., Bakker, E. D., Jonsson, M., Abrahamson, M., Nyman, U., Björk, J., Lindström, V., Larsson, A., Bökenkamp, A., & Grubb, A. (2017). Estimating glomerular filtration rate (GFR) in children. The average between a cystatin C- and a creatinine-based equation improves estimation of GFR in both children and adults and enables diagnosing Shrunken Pore Syndrome. Scandinavian Journal of Clinical and Laboratory Investigation, 77(5): 338–344. https://doi.org/10.1080/00365513.2017.1324175
• Almén, M. S., Björk, J., Nyman, U., Lindström, V., Jonsson, M., Abrahamson, M., Vestergren, A. S., Lindhe, Ö., Franklin, G., Christensson, A., & Grubb, A. (2018). Shrunken pore syndrome is associated with increased levels of Atherosclerosis-Promoting proteins. Kidney International Reports, 4(1): 67–79. https://doi.org/10.1016/j.ekir.2018.09.002
• Åkesson, A., Lindström, V., Nyman, U., Jonsson, M., Abrahamson, M., Christensson, A., Björk, J., & Grubb, A. (2020). Shrunken pore syndrome and mortality: a cohort study of patients with measured GFR and known comorbidities. Scandinavian Journal of Clinical and Laboratory Investigation, 80(5): 412–422. https://doi.org/10.1080/00365513.2020.1759139
• Zhang, L., Luo, M., Xie, X., You, Z., Zeng, J., Lin, M., Chen, L., Lin, K., & Guo, Y. (2022). Shrunken pore syndrome: a new and more powerful phenotype of renal dysfunction than chronic kidney disease for predicting Contrast‐Associated acute kidney injury. Journal of the American Heart Association, 12(1): e027980. https://doi.org/10.1161/jaha.122.027980
• Spencer, S., Desborough, R., & Bhandari, S. (2023). Should cystatin C EGFR become routine clinical practice? Biomolecules, 13(7): 1075. https://doi.org/10.3390/biom13071075
• Agrawal, P., Singh, S., Khurana, M., Agarwal, K., Pursnani, N., & Gautam, A. (2022). Interpretation of urine routine report of a diabetic patient. Journal of Diabetology, 13(4): 317–321. https://doi.org/10.4103/jod.jod_89_22
• Åkesson, A., Lindström, V., Nyman, U., Jonsson, M., Abrahamson, M., Christensson, A., Björk, J., & Grubb, A. (2020b). Shrunken pore syndrome and mortality: a cohort study of patients with measured GFR and known comorbidities. Scandinavian Journal of Clinical and Laboratory Investigation, 80(5): 412–422. https://doi.org/10.1080/00365513.2020.1759139
• Wu, Z., Wang, L., Li, Y., Yao, Y., & Zeng, R. (2022). Shrunken Pore Syndrome Is Associated with Renal Function Decline in Female Patients with Kidney Diseases. BioMed Research International, 2022(1): 2177991. https://doi.org/10.1155/2022/2177991
• Xhakollari, L., Jujic, A., Molvin, J., Nilsson, P., Holm, H., Bachus, E., Leosdottir, M., Grubb, A., Christensson, A., & Magnusson, M. (2021). Proteins linked to atherosclerosis and cell proliferation are associated with the shrunken pore syndrome in heart failure patients. PROTEOMICS - CLINICAL APPLICATIONS, 15(4): e2000089. https://doi.org/10.1002/prca.202000089
• Bakker, E. D., Gemke, R. J., Van Wijk, J. A., Hubeek, I., Stoffel-Wagner, B., & Bökenkamp, A. (2019). Evidence for shrunken pore syndrome in children. Scandinavian Journal of Clinical and Laboratory Investigation, 80(1): 32–38. https://doi.org/10.1080/00365513.2019.1692231
• Kasper, P., Martin, A., Lang, S., Kütting, F., Goeser, T., Demir, M., & Steffen, H. (2020). NAFLD and cardiovascular diseases: a clinical review. Clinical Research in Cardiology, 110(7): 921–937. https://doi.org/10.1007/s00392-020-01709-7
• Mutruc, V., Bologa, C., Șorodoc, V., Ceasovschih, A., Morărașu, B. C., Șorodoc, L., Catar, O. E., & Lionte, C. (2025). Cardiovascular–Kidney–Metabolic syndrome: a new paradigm in clinical medicine or going back to basics? Journal of Clinical Medicine, 14(8): 2833. https://doi.org/10.3390/jcm14082833
• Morales-Suarez-Varela, M., & Guillen-Grima, F. (2025). Cardiovascular Risk During Pregnancy: Scoping Review on the Clinical Implications and Long-Term Consequences. Journal of Clinical Medicine, 14(21): 7516. https://doi.org/10.3390/jcm14217516
• Doiron, R. C. (2020). A GRADE approach hits the mark in the new CUA male urethral stricture guideline. Canadian Urological Association Journal, 14(10): 317–318. https://doi.org/10.5489/cuaj.6940
• Langan, S., & Benchimol, E. (2016). The need to improve reporting of routinely collected dermatology data for patient benefit. British Journal of Dermatology, 174(3): 477–480. https://doi.org/10.1111/bjd.14433